Specifically, AR has been shown to interact with growth factor receptors like EGFR and TrkA, as well as with metalloproteases in prostate cancer, which can influence AR signaling dynamics and enhance tumor progression (29–32). The gene discussed is AR; the disease is prostate carcinoma.